Drug Type Monoclonal antibody |
Synonyms Anti-IL-20, Fletikumab (USAN/INN) + [3] |
Target |
Mechanism IL-20 inhibitors(Interleukin 20 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D11756 | Fletikumab | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Phase 2 | RO | 01 Feb 2011 | |
Rheumatoid Arthritis | Phase 2 | ES | 01 Feb 2011 | |
Rheumatoid Arthritis | Phase 2 | DE | 01 Feb 2011 | |
Rheumatoid Arthritis | Phase 2 | CZ | 01 Feb 2011 | |
Rheumatoid Arthritis | Phase 2 | PL | 01 Feb 2011 | |
Rheumatoid Arthritis | Phase 2 | PL | 01 Feb 2011 | |
Rheumatoid Arthritis | Phase 2 | DE | 01 Feb 2011 | |
Rheumatoid Arthritis | Phase 2 | CZ | 01 Feb 2011 | |
Rheumatoid Arthritis | Phase 2 | RO | 01 Feb 2011 | |
Rheumatoid Arthritis | Preclinical | ES | 01 Feb 2011 |
Phase 2 | 67 | (zhoodhifpf): difference = -0.88, P-Value = 0.02 View more | Positive | 01 Jun 2015 | |||
Placebo |